GPR17 Polyclonal Antibody

Dual specificity receptor for uracil nucleotides and cysteinyl leukotrienes (CysLTs). Signals through G(i) and inhibition of adenylyl cyclase. May mediate brain damage by nucleotides and CysLTs following ischemia.

The GPR17 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of GPR17 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards GPR17.

GPR17, also known as G protein-coupled receptor 17, is a member of the G protein-coupled receptor family. It plays a crucial role in various physiological processes, including cell proliferation, differentiation, and migration. Dysregulation of GPR17 has been implicated in several diseases, making it an important target for research and therapeutic development.

The GPR17 Polyclonal Antibody exhibits exceptional performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of GPR17 protein in a wide range of species, including human, mouse, and rat.

This antibody is manufactured under stringent quality control measures to ensure batch-to-batch consistency and reproducibility. It has been validated for its specificity and sensitivity, providing reliable and accurate results. The GPR17 Polyclonal Antibody is supplied as a liquid formulation, ready to use for immediate experimentation.

In summary, the GPR17 Polyclonal Antibody is a valuable tool for researchers studying GPR17 protein expression and its role in various biological processes. Its high specificity, sensitivity, and versatility make it an ideal choice for a wide range of applications.